Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...

Shares of Coherus BioSciences rose 4.5% to $1.8 in pre-market activity after it released positive med-stage results for its ...

One of the best ways to address the gap between healthcare providers and patients is by making diagnostic processes more ...

A man looks at an electronic board displaying the Nikkei stock average outside a brokerage in Tokyo, Japan, August 6, 2024. REUTERS/Willy Kurniawan/File Photo A look at the day ahead in Asian markets.

The funding will be strategically allocated to support ongoing research and development initiatives, with particular emphasis on fueling progress with OKYO's lead program, OK-101 focused on treating ...

Market ends at a six-month low amid extreme volatility. Nifty breaches 23,000 intra-day for the first time since June 2024. Stocks see big earnings reaction; Zomato, MCX, Oberoi, and Dixon fall 10-15% ...